PubMed

Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease.

Filler G, Sharma AP, Levy DM, Yasin A.

Pediatr Rheumatol Online J. 2010 Jan 4;8(1):1. [Epub ahead of print]PMID: 20047676 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.

de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA.

Clin Pharmacokinet. 2008;47(12):827-38. doi: 10.2165/0003088-200847120-00007.PMID: 19026038 [PubMed - indexed for MEDLINE]Related citations

Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.

Hummel M, Yonan N, Ross H, Miller LW, Sechaud R, Balez S, Koelle EU, Gerosa G; ERL 2401 Study Group.

Clin Transplant. 2007 Jan-Feb;21(1):18-23.PMID: 17302587 [PubMed - indexed for MEDLINE]Related citations

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.

Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W.

Transplantation. 2007 Feb 27;83(4):417-24.PMID: 17318074 [PubMed - indexed for MEDLINE]Related citations

Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.

Tedesco-Silva H, Bastien MC, Choi L, Felipe C, Campestrini J, Picard F, Schmouder R.

Transplant Proc. 2005 Mar;37(2):852-5.PMID: 15848554 [PubMed - indexed for MEDLINE]Related citations

A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.

Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.

Clin Ther. 2006 Jun;28(6):893-905.PMID: 16860172 [PubMed - indexed for MEDLINE]Related citations

Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.

Arns W, Breuer S, Choudhury S, Taccard G, Lee J, Binder V, Roettele J, Schmouder R.

Clin Transplant. 2005 Apr;19(2):199-206.PMID: 15740555 [PubMed - indexed for MEDLINE]Related citations

Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.

Djabarouti S, Duffau P, Lazaro E, Chapouly C, Greib C, Viallard JF, Pellegrin JL, Saux MC, Breilh D.

Expert Opin Pharmacother. 2010 Apr;11(5):689-99.PMID: 20210680 [PubMed - indexed for MEDLINE]Related citations

Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.

Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N; ERL2401 Heart Study Investigators.

J Heart Lung Transplant. 2006 Aug;25(8):935-41. Epub 2006 Jun 27.PMID: 16890114 [PubMed - indexed for MEDLINE]Related citations

Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.

Tedesco-Silva H, Felipe CR, Park SI, Pinheiro-Machado PG, Garcia R, Slade A, Schmouder R, Medina-Pestana JO.

Clin Transplant. 2009 Dec 28. [Epub ahead of print]PMID: 20047618 [PubMed - as supplied by publisher]Related citations

Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.

Budde K, Bauer S, Hambach P, Hahn U, Röblitz H, Mai I, Diekmann F, Neumayer HH, Glander P.

Am J Transplant. 2007 Apr;7(4):888-98. Erratum in: Am J Transplant. 2007 Aug;7(8):2057. PMID: 17391132 [PubMed - indexed for MEDLINE]Related citations

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Staatz CE, Tett SE.

Clin Pharmacokinet. 2007;46(1):13-58. Review.PMID: 17201457 [PubMed - indexed for MEDLINE]Related citations

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Budde K, Knoll G, Curtis J, Chan L, Pohanka E, Gentil M, Seifu Y, Marrast AC, Neumayer HH; ERL B302 Study Group.

Clin Nephrol. 2006 Aug;66(2):103-11.PMID: 16939066 [PubMed - indexed for MEDLINE]Related citations

Review of the immunosuppressant enteric-coated mycophenolate sodium.

Budde K, Glander P, Diekmann F, Waiser J, Fritsche L, Dragun D, Neumayer HH.

Expert Opin Pharmacother. 2004 Jun;5(6):1333-45. Review.PMID: 15163278 [PubMed - indexed for MEDLINE]Related citations

Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil.

Sánchez Fructuoso A, Calvo N, Moreno MA, Giorgi M, Conesa J, Barrientos A.

Transplant Proc. 2007 Sep;39(7):2194-6.PMID: 17889135 [PubMed - indexed for MEDLINE]Related citations

Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing.

Filler G, Lathia A, LeBlanc C, Christians U.

Pediatr Nephrol. 2006 Aug;21(8):1206-8. Epub 2006 May 24.PMID: 16721583 [PubMed - indexed for MEDLINE]Related citations

Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.

Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH.

Transplant Proc. 2004 Mar;36(2 Suppl):524S-527S.PMID: 15041401 [PubMed - indexed for MEDLINE]Related citations

Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.

Zhang Q, Tao Y, Zhu Y, Zhu D.

Clin Ther. 2010 Jan;32(1):171-8.PMID: 20171422 [PubMed - indexed for MEDLINE]Related citations

Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.

Filler G, Foster J, Berard R, Mai I, Lepage N.

Transplant Proc. 2004 Jun;36(5):1327-31.PMID: 15251324 [PubMed - indexed for MEDLINE]Related citations

Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.

Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.

Ther Drug Monit. 2006 Oct;28(5):623-31.PMID: 17038876 [PubMed - indexed for MEDLINE]Related citations